Suchergebnisse - "Mosterd, Charlotte M"

PubPharm (11)

1

Sex differences in associations of plasma metabolites with blood pressure and heart rate variability : The HELIUS study

enthalten in: Atherosclerosis | 2023

von Verhaar, B. | Mosterd, C. | Collard, D. | +6

2

Exposure-Response Analysis of the Sodium-Glucose Cotransporter-2 Inhibitors Dapagliflozin and Empagliflozin on Kidney Hemodynamics in Patients with Type 2 Diabetes

enthalten in: Journal of personalized medicine | 2023

von van der Hoek, S. | Koomen, J. | van Bommel, E. | +6

3

Mechanisms underlying the blood pressure-lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes : A secondary analysis of a randomized crossover trial

enthalten in: Diabetes, obesity & metabolism | 2023

von Scholtes, R. | Mosterd, C. | Hesp, A. | +3

4

Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes : A secondary analysis of a randomized crossover trial

enthalten in: Diabetes, Obesity and Metabolism | 2023

von Scholtes, R. | Mosterd, C. | Hesp, A. | +3

5

Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination : A Crossover Randomized Trial in People With Type 2 Diabetes

enthalten in: Circulation | 2022

von Scholtes, R. | Hesp, A. | Mosterd, C. | +7

6

Ethnic disparities in the association between low-grade inflammation biomarkers and chronic kidney disease : The HELIUS Cohort Study

enthalten in: Journal of diabetes and its complications | 2022

von Mosterd, C. | Hayfron-Benjamin, C. | van den Born, B. | +3

7

Differences in Body Composition Convey a Similar Risk of Type 2 Diabetes Among Different Ethnic Groups With Disparate Cardiometabolic Risk-The HELIUS Study

enthalten in: Diabetes care | 2021

von Zethof, M. | Mosterd, C. | Collard, D. | +5

8

Nephroprotective effects of GLP-1 receptor agonists : where do we stand?

enthalten in: Journal of nephrology | 2020

von Mosterd, C. | Bjornstad, P. | van Raalte, D.

9

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

enthalten in: Journal of nephrology | 2020

von Mosterd, C. | Bjornstad, P. | van Raalte, D.

10

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

enthalten in: Journal of nephrology / Supplement | 2020

von Mosterd, C. | Bjornstad, P. | van Raalte, D.